Page 1919 - Williams Hematology ( PDFDrive )

1894 Part XII: Hemostasis and Thrombosis Chapter 112: Platelet Morphology, Biochemistry, and Function 1895

531. Houng A, Polgar J, Reed GL: Munc18-syntaxin complexes and exocytosis in human 565. Johnson AD, et al: Genome-wide meta-analyses identifies seven loci associated with
platelets. J Biol Chem 278(22):19627–19633, 2003. platelet aggregation in response to agonists. Nat Genet 42(7):608–613, 2010.
532. Schraw TD, et al: Platelets from Munc18c heterozygous mice exhibit normal stimu- 566. Oliver KH, et al: Pro32Pro33 mutations in the integrin beta3 PSI domain result in
lus-induced release. Thromb Haemost 92(4):829–837, 2004. alphaIIbbeta3 priming and enhanced adhesion: Reversal of the hypercoagulability
533. Schraw TD, et al: A role for Sec1/Munc18 proteins in platelet exocytosis. Biochem J phenotype by the Src inhibitor SKI-606. Mol Pharmacol 85(6):921–931, 2014.
374(Pt 1):207–217, 2003. 567. Kritzik M, et al: Nucleotide polymorphisms in the alpha2 gene define multiple alle-
534. Sandrock K, et al: Platelet secretion defect in patients with familial hemophagocytic les that are associated with differences in platelet alpha2 beta1 density. Blood 92(7):
lymphohistiocytosis type 5 (FHL-5). Blood 116(26):6148–6150, 2010. 2382–2388, 1998.
535. Suzuki T, et al: The mouse organellar biogenesis mutant buff results from a mutation 568. Roest M, et al: Platelet adhesion to collagen in healthy volunteers is influenced by
in Vps33a, a homologue of yeast vps33 and Drosophila carnation. Proc Natl Acad Sci U variation of both alpha(2)beta(1) density and von Willebrand factor. Blood 96(4):
S A 100(3):1146–1150, 2003. 1433–1437, 2000.
536. Urban D, et al: The VPS33B-binding protein VPS16B is required in megakaryocyte 569. Joutsi-Korhonen L, et al: The low-frequency allele of the platelet collagen signaling
and platelet alpha-granule biogenesis. Blood 120(25):5032–5040, 2012. receptor glycoprotein VI is associated with reduced functional responses and expres-
537. Ye S, et al: Platelet secretion and hemostasis require syntaxin-binding protein sion. Blood 101(11):4372–4379, 2003.
STXBP5. J Clin Invest 124(10):4517–4528, 2014. 570. Jones CI, et al: A functional genomics approach reveals novel quantitative trait loci
538. Lillicrap D, Syntaxin-binding protein 5 exocytosis regulation: Differential role in associated with platelet signaling pathways. Blood 114(7):1405–1416, 2009.
endothelial cells and platelets. J Clin Invest 124(10):4231–4233, 2014. 571. Musunuru K, et al: Association of single nucleotide polymorphisms on chromosome
539. Zhu Q, et al: STXBP5 regulates endothelial exocytosis, plasma VWF levels, and plate- 9p21.3 with platelet reactivity: A potential mechanism for increased vascular disease.
let endothelial interactions. Clin Invest 124(10):4503–4516, 2014. Circulation. Circ Cardiovasc Genet 3(5):445–453, 2010.
540. James DJ, Martin TF: CAPS and Munc13: CATCHRs that SNARE Vesicles. Front 572. Edelstein LC, et al: Human genome-wide association and mouse knockout approaches
Endocrinol (Lausanne) 4:187, 2013. identify platelet supervillin as an inhibitor of thrombus formation under shear stress.
541. Ren Q, et al: Munc13–4 is a limiting factor in the pathway required for platelet granule Circulation 125(22):2762–2771, 2012.
release and hemostasis. Blood 2010;116(6):869–877, 2013. 573. Gieger C, et al: New gene functions in megakaryopoiesis and platelet formation.
542. Nakamura L, et al: First characterization of platelet secretion defect in patients with Nature 480(7376):201–208, 2011.
familial hemophagocytic lymphohistiocytosis type 3 (FHL-3). Blood 125(2):412–414, 574. Weyrich AS, et al: Protein synthesis by platelets: Historical and new perspectives. J
2015. Thromb Haemost 7(2):241–246, 2009.
543. Barral DC, et al: Functional redundancy of Rab27 proteins and the pathogenesis of 575. Denis MM, et al: Escaping the nuclear confines: Signal-dependent pre-mRNA splicing
Griscelli syndrome. J Clin Invest 110(2):247–257, 2002. in anucleate platelets. Cell 122(3):379–391, 2005.
544. Hampson A, O’Connor A, Smolenski A: Synaptotagmin-like protein 4 and Rab8 inter- 576. Edelstein LC, et al: MicroRNAs in platelet production and activation. J Thromb Hae-
act and increase dense granule release in platelets. J Thromb Haemost 11(1):161–168, most 11 Suppl 1:340–350, 2013.
2013. 577. Gnatenko DV, et al: Transcript profiling of human platelets using microarray and
545. Janka GE: Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev serial analysis of gene expression. Blood 101(6):2285–2293, 2003.
Med 63:233–246, 2012. 578. Bugert P, et al: Messenger RNA profiling of human platelets by microarray hybridiza-
546. Lindemann S, et al: Platelets, inflammation and atherosclerosis. J Thromb Haemost 5 tion. Thromb Haemost 90(4):738–748, 2003.
(Suppl 1):203–211, 2007. 579. Schubert S, Weyrich AS, Rowley JW: A tour through the transcriptional landscape of
547. Bray PF: Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr platelets. Blood 124(4):493–502, 2014.
Opin Hematol 7(5):284–289, 2000. 580. Rowley JW, et al: Genome-wide RNA-seq analysis of human and mouse platelet tran-
548. Deloukas P, et al: Large-scale association analysis identifies new risk loci for coronary scriptomes. Blood 118(14):e101–e111, 2011.
artery disease. Nat Genet 45(1):25–33, 2013. 581. Bray PF, McKenzie SE, Edelstein LC, et al: The complex transcriptional landscape of
549. Bray PF, Jones CI, Soranzo N, Ouwehand WH: Platelet genomics, in Platelets, edited the anucleate human platelet. BMC Genomics 14(1):1, 2013.
by A Michelson, Editor. Academic Press, San Diego, 2012. 582. Simon LM, Edelstein LC, Nagalla S, et al: Human platelet microRNA-mRNA net-
550. Albers CA, et al: Exome sequencing identifies NBEAL2 as the causative gene for gray works associated with age and gender revealed by integrated plateletomics. Blood
platelet syndrome. Nat Genet 43(8):735–737, 2011. 123(16):e37–e45, 2014.
551. Gunay-Aygun M, et al: NBEAL2 is mutated in gray platelet syndrome and is required 583. Wang Z, et al: The role of mitochondria-derived reactive oxygen species in hyper-
for biogenesis of platelet alpha-granules. Nat Genet 43(8):732–734, 2011. thermia-induced platelet apoptosis. PLoS One 8(9):e75044, 2013.
552. Hulot JS, et al: Cytochrome P450 2C19 loss-of-function polymorphism is a major 584. Hayashi T, Tanaka S, Hori Y, et al: Role of mitochondria in the maintenance of platelet
determinant of clopidogrel responsiveness in healthy subjects. Blood 108(7): function during in vitro storage. Transfus Med 21(3):166–174, 2011.
2244–2247, 2006. 585. Shim MH, et al: Gene expression profile of primary human CD34+CD38lo cells dif-
553. Shuldiner AR, et al: Association of cytochrome P450 2C19 genotype with the anti- ferentiating along the megakaryocyte lineage. Exp Hematol 32(7):638–648, 2004.
platelet effect and clinical efficacy of clopidogrel therapy. JAMA 302(8):849–857, 586. Tenedini E, et al: Gene expression profiling of normal and malignant CD34-derived
2009. megakaryocytic cells. Blood 104(10):3126–3135, 2004.
554. Mega JL, et al: Reduced-function CYP2C19 genotype and risk of adverse clinical out- 587. Healy AM, et al: Platelet expression profiling and clinical validation of myeloid-re-
comes among patients treated with clopidogrel predominantly for PCI: A meta-anal- lated protein-14 as a novel determinant of cardiovascular events. Circulation 113(19):
ysis. JAMA 304(16):1821–1830, 2010. 2278–2284, 2006.
555. Holmes MV, et al: CYP2C19 genotype, clopidogrel metabolism, platelet function, and 588. Morrow DA, et al: Myeloid-related protein 8/14 and the risk of cardiovascular death
cardiovascular events: A systematic review and meta-analysis. JAMA 306(24):2704– or myocardial infarction after an acute coronary syndrome in the Pravastatin or Ator-
2714, 2011. vastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction
556. Yee D, et al: Platelet hyperreactivity to submaximal epinephrine: Biologic and clinical (PROVE IT-TIMI 22) trial. Am Heart J 155(1):49–55, 2008.
correlates. 106(8):2723–2729, 2005. 589. Gnatenko DV, et al: Platelets express steroidogenic 17beta-hydroxysteroid dehydro-
557. Bray PF, et al: Heritability of platelet function in families with premature coronary genases. Distinct profiles predict the essential thrombocythemic phenotype. Thromb
artery disease. J Thromb Haemost 2007;5(8):1617–1623, 2005. Haemost 94(2):412–421, 2005.
558. Newman PJ, Derbes RS, Aster RH: The human platelet alloantigens, PlA1 and PlA2, 590. Gnatenko DV, et al: Class prediction models of thrombocytosis using genetic
are associated with a leucine33/proline33 amino acid polymorphism in mem- biomarkers. Blood 115(1):7–14, 2010.
brane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 83(5): 591. Sun L, et al: Decreased platelet expression of myosin regulatory light chain polypep-
1778–1781, 1989. tide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation:
559. Vijayan KV, et al: Fibrinogen and prothrombin binding is enhanced to the Pro33 iso- Insights from platelet expression profiling. J Thromb Haemost 5(1):146–154, 2007.
form of purified integrin alphaIIbbeta3. J Thromb Haemost 4(4):905–906, 2006. 592. Kahr WH, et al: Mutations in NBEAL2, encoding a BEACH protein, cause gray plate-
560. Vijayan KV, et al: The Pl(A2) polymorphism of integrin beta(3) enhances outside-in let syndrome. Nat Genet 43(8):738–740, 2011.
signaling and adhesive functions. J Clin Invest 105(6):793–802, 2000. 593. Nanda N, et al: Platelet endothelial aggregation receptor 1 (PEAR1), a novel epider-
561. Sajid M, et al: PlA polymorphism of integrin beta 3 differentially modulates cel- mal growth factor repeat-containing transmembrane receptor, participates in platelet
lular migration on extracellular matrix proteins. Arterioscler Thromb Vasc Biol contact-induced activation. J Biol Chem 280(26):24680–24689, 2005.
22(12):1984–1989, 2002. 594. Kondkar AA, et al: VAMP8/endobrevin is overexpressed in hyperreactive human
562. Vijayan KV, et al: Shear stress augments the enhanced adhesive phenotype of cells platelets: Suggested role for platelet microRNA. J Thromb Haemost 8(2):369–378,
expressing the Pro33 isoform of integrin beta3. FEBS Lett 540(1–3):41–46, 2003. 2010.
563. Vijayan KV, et al: Enhanced activation of mitogen-activated protein kinase and myo- 595. Goodall AH, et al: Transcription profiling in human platelets reveals LRRFIP1 as a
sin light chain kinase by the Pro33 polymorphism of integrin beta 3. J Biol Chem novel protein regulating platelet function. Blood 116(22):4646–4656, 2010.
278(6):3860–3867, 2003. 596. Edelstein LC, Simon LM, Montoya RT, et al: Racial differences in human platelet PAR4
564. Vijayan KV, et al: The Pro33 isoform of integrin beta3 enhances outside-in signaling reactivity reflect expression of PCTP and miR-376c. Nat Med 19(12):1609–1616, 2013.
in human platelets by regulating the activation of serine/threonine phosphatases. J 597. Carninci P, et al: The transcriptional landscape of the mammalian genome. Science
Biol Chem 280(23):21756–21762, 2005. 309(5740):1559–1563, 2005.

Kaushansky_chapter 112_p1829-1914.indd 1894 17/09/15 3:30 pm